This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The purpose of this study is to assess the efficiency of a well-tolerated oral dose of RGH-896 compared with that of placebo administered for 4 weeks in reducing neuropathic pain associated with spinal cord injury. This is an investigator-initiated study.
Showing the most recent 10 out of 721 publications